OUR FUTURE HEALTH
Get an alert when OUR FUTURE HEALTH files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-09-30 (in 4mo)
Last made up 2025-09-16
Watchouts
None on the register
Cash
£11M
+12.1% vs 2024
Net assets
£31M
-29.4% vs 2024
Employees
243
+46.4% vs 2024
Profit before tax
—
Period ending 2025-03-31
Name history
Renamed 1 time since incorporation
- OUR FUTURE HEALTH 2020-12-09 → present
- EARLY DISEASE DETECTION RESEARCH PROJECT UK 2019-09-17 → 2020-12-09
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £80,268,925 | £97,922,773 | |
| Operating profit | — | — | |
| Profit before tax | — | — | |
| Net profit | -£5,172,308 | -£12,936,809 | |
| Cash | £9,477,524 | £10,625,275 | |
| Total assets less current liabilities | £43,960,704 | £31,023,895 | |
| Net assets | £43,960,704 | £31,023,895 | |
| Equity | £43,960,704 | £31,023,895 | |
| Average employees | 166 | 243 | |
| Wages | £12,159,258 | £18,264,225 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Net margin | -6.4% | -13.2% | |
| Gearing (liabilities / total assets) | 15.0% | 26.4% | |
| Current ratio | 5.81x | 3.03x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Saffery LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“It is based on this combination of information that the Trustees consider that it is appropriate to prepare the accounts on a going concern basis.”
Group structure
- OUR FUTURE HEALTH · parent
- Our Future Health Trading Limited 1%
Significant events
- “FY24-25 saw further government funding support from the Office for Life Sciences of £16.9m.”
- “Our Future Health welcome further Funding Charity Partners, Life Arc and the British Heart Foundation, who will support the organisation and the development of the programme.”
- “FY24-25 also saw continued invaluable support from our 16 Industry Partners. Various contractual milestones were achieved, which was the main driver behind £27.4m of income from other trading activities.”
- “Our workforce grew from 215 to 270 people between April '24 and March '25.”
- “Received ISO 27001, Cyber Essentials Plus, and NHS Data Security & Protection Toolkit certifications.”
- “An additional UK Government grant of £51m (less administrative fees) was issued by the Department for Science, Innovation and Technology (DSIT) to further support the costs of establishing the programme, which was added to the UKRI funding to be spent by 31st March 2025. £38m of this income was recognised in the year issued, and the remaining income was recognised in FY24-25.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
13 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BELL, John Irving | Director | 2019-09-17 | Jul 1952 | British,Canadian |
| CALAM, Mary Jane | Director | 2022-02-21 | Oct 1969 | British |
| CHAMBRE, Peter Alan | Director | 2022-01-31 | Nov 1955 | British,German |
| DEANFIELD, John Eric, Professor | Director | 2023-07-06 | Apr 1952 | British |
| HENNAH, Adrian Nevil | Director | 2022-01-31 | Nov 1957 | British |
| KUMAR, Harpal Singh, Dr | Director | 2019-09-17 | Jan 1965 | British |
| MALIK, Kemal Zulfiqar | Director | 2022-01-31 | Sep 1962 | British |
| MARTIN, Ciaran Liam, Professor | Director | 2022-09-23 | Sep 1974 | British,Irish |
| OSMAN, Sally | Director | 2022-02-21 | May 1959 | British |
| PEAKMAN, Timothy Charles | Director | 2020-01-21 | Nov 1963 | British |
| SEXTON, Richard George | Director | 2022-01-31 | Jul 1959 | British |
| WATT, Fiona Mary, Dr | Director | 2019-09-17 | Mar 1956 | British |
| WELLS, Glenn Paul, Dr | Director | 2024-12-17 | Jul 1976 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ROBERTS, Samantha, Dr | Director | 2020-01-21 | 2020-11-09 |
| WEISSBERG, Peter Leslie | Director | 2019-09-17 | 2021-03-18 |
| WOOLLEY, Simon Guy | Director | 2022-03-12 | 2024-12-17 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 54 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-30 | AA | accounts | Accounts with accounts type group | |
| 2025-09-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-17 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-02 | AA | accounts | Accounts with accounts type group | |
| 2024-09-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-09 | AA | accounts | Accounts with accounts type group | |
| 2023-09-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-10 | CH01 | officers | Change person director company with change date | |
| 2023-07-10 | CH01 | officers | Change person director company with change date | |
| 2023-07-10 | CH01 | officers | Change person director company with change date | |
| 2023-07-10 | CH01 | officers | Change person director company with change date | |
| 2023-07-10 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
+22%
£80,268,925 £97,922,773
-
Cash
+12.1%
£9,477,524 £10,625,275
-
Net assets
-29.4%
£43,960,704 £31,023,895
-
Employees
+46.4%
166 243
-
Wages
+50.2%
£12,159,258 £18,264,225
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers